Ticker

NewEdge Advisors LLC raised its holdings in iShares U.S. Medical Devices ETF (NYSEARCA:IHI) by 21.4% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 75,655 shares of the company's stock after purchasing an additional 13,341 shares during the quarter. NewEdge

Baird Financial Group Inc. grew its position in shares of iShares U.S. Medical Devices ETF (NYSEARCA:IHI) by 39.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 154,893 shares of the company's stock after buying an additional 43,629 shares

Looking for broad exposure to the Healthcare - Medical Devices segment of the equity market? You should consider the iShares U.S. Medical Devices ETF (IHI), a passively managed exchange traded fund launched on May 1, 2006.

iShares U.S. Medical Devices ETF is rated a sell due to historical underperformance, high concentration risk, and elevated valuation. IHI's top three holdings—ABT, ISRG, SYK—comprise nearly 43% of the portfolio, amplifying downside risk if growth falters or valuations compress. The ETF's 34x PE and sub-0.5% yield create an unattractive risk-reward profile, especially given its 18–20% volatility and minimal income.

iShares U.S. Medical Devices ETF (NYSEARCA:IHI - Get Free Report) was the target of some unusual options trading on Monday. Stock investors bought 20,198 put options on the company. This is an increase of 524% compared to the typical volume of 3,237 put options. Institutional Trading of iShares U.S. Medical Devices ETF Hedge funds have